Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Prices Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced last night that it has priced an aggregate principal amount of $300 million of senior notes due 2020 through a public offering.

The St. Louis-based research products and chemicals firm said that it would use proceeds from the offering for general corporate purposes.

The notes have a 10-year maturity, an issue price of 99.915 percent, and a fixed rate coupon of 3.375 percent, payable semi-annually.

Sigma-Aldrich expects to complete the offering on Oct. 28.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.